Medication info

Motin Injection (Famotidine)

Prescription medicationInjectionsOral · Intravenous injection
Ingredient · strength
Famotidine›2mg / 1mL
Manufacturer / importer
Myongin Pharmaceuticals Co., Ltd.
Appearance
A clear liquid that is colorless to pale yellow contained in a colorless and transparent vial.
Packaging
10 vials/box [(10 milliliters/vial × 10)]
Approval status
Active

MFDS item code 202502157 · Approved 2025.08.20 · Insurance code 651905431

Summary

Main use
Control of upper gastrointestinal bleeding, pre-anesthetic medication, and treatment of Zollinger-Ellison syndrome
Who uses it
Adults
Adult dosage
Upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or hemorrhagic gastritis), Zollinger-Ellison syndrome, and prevention of upper gastrointestinal bleeding caused by physical stress (after major surgery, severe cerebrovascular disorders, head trauma, multiple organ failure, or severe burns): In adults, dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose. Administer by slow intravenous injection twice daily (every 12 hours) or by intravenous infusion after mixing with an infusion solution. - Upper gastrointestinal bleeding and Zollinger-Ellison syndrome : The effect generally appears within 1 week. Switch to oral administration once oral administration is possible. - Prevention of upper gastrointestinal bleeding : Administer for about 3 days for physical stress after major surgery and about 7 days for other physical stress. When used as preanesthetic medication, dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose, and administer by slow intravenous injection 1 hour before induction of anesthesia. After dilution, use within 48 hours if stored at room temperature or refrigerated. The dosage may be adjusted appropriately according to age and symptoms.

Ingredients

Manufacturer
Myongin Pharmaceuticals Co., Ltd.

Efficacy & effects

Control of upper gastrointestinal bleeding, pre-anesthetic medication, and treatment of Zollinger-Ellison syndrome

  • Upper gastrointestinal bleeding
  • peptic ulcer
  • acute stress ulcer
  • hemorrhagic gastritis
  • Zollinger-Ellison syndrome
  • physical stress
  • severe cerebrovascular disorders
  • head trauma
  • multiple organ failure
  • severe burns.
View approved original text

This medication is used to inhibit upper gastrointestinal bleeding. The main indications include bleeding due to peptic ulcers, acute stress ulcers, and hemorrhagic gastritis. Additionally, it is effective in inhibiting bleeding that occurs due to Zollinger-Ellison syndrome and physical stress conditions, such as after major surgery, severe cerebrovascular disorders, head trauma, multiple organ failure, and severe burns. It is also used as a pre-anesthetic to help prevent bleeding. This medication is safely used to inhibit bleeding in patients at high risk for gastric bleeding.

Dosage and Administration

Adult dosage

Upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or hemorrhagic gastritis), Zollinger-Ellison syndrome, and prevention of upper gastrointestinal bleeding caused by physical stress (after major surgery, severe cerebrovascular disorders, head trauma, multiple organ failure, or severe burns): In adults, dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose. Administer by slow intravenous injection twice daily (every 12 hours) or by intravenous infusion after mixing with an infusion solution. - Upper gastrointestinal bleeding and Zollinger-Ellison syndrome : The effect generally appears within 1 week. Switch to oral administration once oral administration is possible. - Prevention of upper gastrointestinal bleeding : Administer for about 3 days for physical stress after major surgery and about 7 days for other physical stress. When used as preanesthetic medication, dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose, and administer by slow intravenous injection 1 hour before induction of anesthesia. After dilution, use within 48 hours if stored at room temperature or refrigerated. The dosage may be adjusted appropriately according to age and symptoms.

Precautions

This medication must not be used in patients who have had allergic reactions to any components of this drug. In patients with poor kidney function, this medication can remain in the body for a long time, so dosage should be reduced or administration intervals extended for careful use. Patients with heart diseases may experience cardiac effects from this drug, so careful observation of the patient's condition after administration is necessary. In patients with decreased liver function, symptoms may worsen, so caution is advised. Elderly patients are likely to have declining kidney function, which may increase the concentration of this medication in the blood, requiring dosage adjustments. This drug can cause serious allergic reactions or shock; if any abnormal symptoms occur during administration, it should be stopped immediately and appropriate treatment should be sought. Serious side effects may occur with a decrease in blood cell count; regular blood tests are necessary. Symptoms of serious inflammation or necrosis in skin and mucous membranes may arise, and the drug should be discontinued immediately if skin abnormalities occur. Liver dysfunction or symptoms of jaundice may develop, so liver status should be regularly monitored. Rhabdomyolysis, characterized by muscle breakdown, may occur, and any symptoms of muscle pain or changes in urine color should be reported immediately. Abnormal electrical activity in the heart may lead to arrhythmias, so close observation of heart condition is required. Consciousness disturbance or seizures may occur, especially in patients with reduced kidney function, thus extra caution is needed. Inflammation of the kidneys or acute renal failure may occur, so if there are symptoms of fever, skin rash, or abnormalities in kidney function tests, administration should be discontinued immediately. This medication is used for the prevention of gastric bleeding during severe physical stress and is limited to use only in postoperative or severely ill patients. The treatment duration should be kept minimal based on symptoms, and if there is no effect, switching to other treatment methods is recommended. There may be interactions with other medications, so particular caution is needed when taking antifungal agents or certain chemotherapy drugs. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this drug. Breastfeeding women are advised to discontinue breastfeeding as this medication can be passed into breast milk. Safety in pediatric patients has not been fully established, so caution is advised in use. When using an ampule, it should be cleaned properly to avoid contamination with glass fragments. This medication can mask the symptoms of gastric cancer, so it should only be used after confirming that the condition is non-malignant.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • systemic rash
  • angioedema
  • urticaria
  • pancytopenia
  • agranulocytosis
  • aplastic anemia
Show 69 more
  • hemolytic anemia
  • systemic fatigue
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • Lyell syndrome
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • serum enzyme elevation
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • convulsions
  • systemic convulsions
  • interstitial nephritis
  • acute renal failure
  • rash
  • urticaria
  • facial edema
  • leukopenia
  • thrombocytopenia
  • eosinophilia
  • constipation
  • diarrhea
  • soft stools
  • dry mouth
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • stomatitis
  • hypertension
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • heart block
  • bronchospasm
  • AST elevation
  • ALT elevation
  • ALP elevation
  • total bilirubin elevation
  • LDH elevation
  • liver dysfunction
  • systemic fatigue
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • paresthesia
  • heaviness
  • reversible confusional state
  • depression
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • CK elevation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and should ideally be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way can maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

A clear liquid that is colorless to pale yellow contained in a colorless and transparent vial.

Package unit

10 vials/box [(10 milliliters/vial × 10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.